Daily antimicrobial prophylaxis is recommended for children with recurrent urinary tract infections (UTI) and vesicoureteral reflux (VUR); however, few studies have investigated the risk factors for ...

For those affected, recurrent urinary tract infections (UTIs) are sometimes stressful. However, even an informative discussion about risk factors and the imparting of behavioral recommendations can be ...

Discover effective strategies to prevent recurrent urinary tract infections and combat antibiotic resistance for better women's health.

Antimicrobial prophylaxis does not reduce the risk of recurrent UTIs in children—but does increase the risk of antibiotic resistance, new data show. Researchers at the University of Pennsylvania in ...

Reviews of Infectious Diseases, Vol. 4, No. 2, Symposium on Trimethoprim-Sulfamethoxazole (TMP-SMZ) (Mar. - Apr., 1982), pp. 438-443 (6 pages) Thirteen women and two preadolescent girls who suffered ...

The urinary antiseptic methenamine hippurate (Hiprex) was non-inferior to antibiotic prophylaxis in women with a history of recurrent urinary tract infections (UTI), according to results from the ...

While primary care physicians are generally comfortable prescribing vaginal estrogen therapy for recurrent urinary tract infections (UTIs), other nonantibiotic prophylactic options remain ...

Please provide your email address to receive an email when new articles are posted on . “We know that UTIs are one of the most common infections leading to hospitalization, and recurrent UTIs are ...

A recent study published in JAMA reports that prophylactic antimicrobials increase the risk of antimicrobial resistance without decreasing the risk of recurrent urinary tract infections (UTIs) in a ...

Please provide your email address to receive an email when new articles are posted on . Nitrofurantoin decreased episodes by 79%, and cranberry juice and tablets reduced episodes by 59% compared with ...

A new clinical guideline on the diagnosis and treatment of recurrent urinary tract infections in women was released by the AUA together with the Canadian Urological Association, and the Society of ...

D-mannose did not reduce the proportion of women with recurrent urinary tract infection (UTI), the randomized, placebo-controlled MERIT trial showed. Over the 6-month study period, 51% of women taking ...